Y-mabs to announce second quarter 2023 financial and operating results on august 10, 2023

New york, aug. 01, 2023 (globe newswire) -- y-mabs therapeutics, inc. (the “company” or “y-mabs”) (nasdaq: ymab) today announced that it will report its financial results for the second quarter ended june 30, 2023, on thursday, august 10, 2023, after the close of the u.s. financial markets. the announcement will be followed by a conference call and webcast with the investment community on friday, august 11, 2023, at 9:00 a.m. et. participating on the call from y-mabs will be thomas gad, founder, chairman and interim chief executive officer, bo kruse, chief financial officer; sue smith, chief commercial officer, and vignesh rajah, chief medical officer.
YMAB Ratings Summary
YMAB Quant Ranking